0000950103-24-000410.txt : 20240108 0000950103-24-000410.hdr.sgml : 20240108 20240108160312 ACCESSION NUMBER: 0000950103-24-000410 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240104 FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Antoniazzi Gilberto CENTRAL INDEX KEY: 0001752661 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38694 FILM NUMBER: 24520031 MAIL ADDRESS: STREET 1: LIVENT CORPORATION, C/O FMC CORPORATION STREET 2: 2929 WALNUT STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Livent Corp. CENTRAL INDEX KEY: 0001742924 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 824688610 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1818 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 215-299-5900 MAIL ADDRESS: STREET 1: 1818 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: FMC Lithium USA Holding Corp. DATE OF NAME CHANGE: 20180606 4 1 dp204998_4-antoniazzi.xml FORM 4 X0508 4 2024-01-04 1 0001742924 Livent Corp. LTHM 0001752661 Antoniazzi Gilberto C/O LIVENT CORPORATION 1818 MARKET STREET, SUITE 2550 PHILADELPHIA PA 19103 0 1 0 0 Vice President and CFO 0 Common Stock 2024-01-04 4 D 0 77991 D 0 D Stock Option (Right to Buy) 23.33 2024-01-04 4 D 0 14914 D 2026-02-22 2033-02-22 Common Stock 14914 0 D Stock Option (Right to Buy) 21.01 2024-01-04 4 D 0 16049 D 2025-02-23 2032-02-23 Common Stock 16049 0 D Stock Option (Right to Buy) 20.35 2024-01-04 4 D 0 53328 D 2024-02-22 2031-02-22 Common Stock 53328 0 D Represents the conversion of common stock and restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into ordinary shares and restricted stock units with respect to ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Ordinary Shares"), in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction. Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction. /s/ Sara Ponessa, as Attorney-in-Fact 2024-01-08